Arch Biopartners Inc. (ACHFF)
ACHFF Stock Price Chart
Explore Arch Biopartners Inc. interactive price chart. Choose custom timeframes to analyze ACHFF price movements and trends.
ACHFF Company Profile
Discover essential business fundamentals and corporate details for Arch Biopartners Inc. (ACHFF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
24 Apr 2002
Employees
—
Website
https://www.archbiopartners.comCEO
Richard Gabriel Muruve
Description
Arch Biopartners Inc., a biotechnology company, develops technologies for medical or commercial impact. It focuses on developing its lead drug candidate Metablok to treat or prevent dipeptidase-1 mediated organ inflammation in the lungs, liver, or kidneys, which results in organ damage or failure, including in the case of sepsis and COVID-19. The company also develops AB569, a drug candidate for treating or preventing antibiotic resistant bacterial infections, primarily as a topical treatment for wounds. In addition, it develops Borg, a peptide-solid surface interface to inhibit biofilm formation and reduce corrosion; and MetaMx, which are synthetic molecules that target brain tumor initiating cells and invasive glioma cells. The company is based in Toronto, Canada.
ACHFF Financial Timeline
Browse a chronological timeline of Arch Biopartners Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 28 May 2026
Upcoming earnings on 26 Jan 2026
Earnings released on 2 Sept 2025
EPS came in at -$0.00 surpassing the estimated -$0.01 by +79.99%, while revenue for the quarter reached $116.11K .
Earnings released on 2 Jun 2025
EPS came in at -$0.01 surpassing the estimated -$0.01 by +55.04%.
Earnings released on 2 Jun 2025
EPS came in at -$0.01 surpassing the estimated -$0.01 by +51.44%.
Earnings released on 3 Mar 2025
EPS came in at -$0.00 surpassing the estimated -$0.01 by +67.99%, while revenue for the quarter reached $81.90K .
Earnings released on 28 Jan 2025
EPS came in at -$0.01 surpassing the estimated -$0.01 by +9.40%, while revenue for the quarter reached -$266.01K .
Earnings released on 29 Aug 2024
EPS came in at -$0.01 falling short of the estimated -$0.01 by -49.93%.
Earnings released on 30 May 2024
EPS came in at -$0.01 matching the estimated -$0.01, while revenue for the quarter reached $1.61M .
Earnings released on 28 Feb 2024
EPS came in at -$0.01 falling short of the estimated -$0.00 by -100.00%, while revenue for the quarter reached $224.48K .
Earnings released on 29 Jan 2024
EPS came in at $0.00 surpassing the estimated -$0.01 by +119.57%, while revenue for the quarter reached -$811.37K .
Earnings released on 29 Aug 2023
EPS came in at -$0.01 falling short of the estimated -$0.01 by -49.93%, while revenue for the quarter reached $87.85K .
Earnings released on 30 May 2023
EPS came in at $0.01 surpassing the estimated $0.01 by +49.93%, while revenue for the quarter reached $1.87M .
Earnings released on 1 Mar 2023
EPS came in at -$0.04 falling short of the estimated -$0.01 by -249.96%, while revenue for the quarter reached $323.98K .
Earnings released on 31 Jan 2023
EPS came in at -$0.01 matching the estimated -$0.01, while revenue for the quarter reached -$433.76K .
Earnings released on 30 Aug 2022
EPS came in at -$0.00 .
Earnings released on 30 May 2022
EPS came in at -$0.01 , while revenue for the quarter reached $898.25K .
Earnings released on 22 Jan 2022
EPS came in at $0.01 , while revenue for the quarter reached $1.47M .
Earnings released on 31 Dec 2021
EPS came in at -$0.00 , while revenue for the quarter reached $341.06K .
Earnings released on 30 Jun 2021
EPS came in at $0.01 , while revenue for the quarter reached $1.61M .
Earnings released on 31 Mar 2021
EPS came in at -$0.01 , while revenue for the quarter reached $16.78K .
Earnings released on 31 Dec 2020
EPS came in at -$0.02 .
Earnings released on 30 Sept 2020
EPS came in at -$0.02 , while revenue for the quarter reached -$13.02K .
ACHFF Stock Performance
Access detailed ACHFF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.